Comment Print Reprint Email

The Pharmaceutical Market: China

BY PR Newswire | 12/05/12 - 06:26 AM EST

Comment

Link

See what Jim Cramer and Stephanie Link are trading today.

Beijing Double-Crane Pharmaceutical79

China Pharmaceutical Group 80

Harbin Pharmaceutical Group 81

Joincare Pharmaceutical Group 82

North China Pharmaceutical 82

Shanghai Pharmaceuticals 83

Tianjin Tasly Pharmaceutical 84

The United Laboratories International 85

Zhejiang Hisun Pharmaceutical86

Zhejiang Medicine 87

OTC PHARMACEUTICALS 89

REGULATION 89

MARKET SIZE 89

COMPETITION 90

Trade Association90

CNMA90

Foreign Company Intelligence90

Sanofi90

Local Company Intelligence 90

China Sky One Medical90

GENERIC PHARMACEUTICALS 92

REGULATION 92

Prescribing Regulation92

MARKET SIZE 92

COMPETITION 92

Foreign Company Intelligence92

AstraZeneca 92

Sandoz 92

Watson93

Local Company Intelligence 93

China Pharma 93

Qilu Pharmaceutical 94

Shanghai Fosun Pharmaceutical 95

BIOLOGICS & BIOSIMILARS 96

REGULATION 96

MARKET SIZE 96

PRODUCT DEVELOPMENT 96

COMPETITION 97

Foreign Company Intelligence97

GlaxoSmithKline 97

Microbix 97

NeoStem97

Sanofi98

Local Company Intelligence 99

3SBIO99

Anhui Anke Biotech100

Beijing SL Pharmaceutical 101

China Biologic Products 102

Harbin Gloria Pharmaceuticals 103

Kun Run Biotechnology 103

Lanzhou Institute of Biological Products103

Livzon Pharmaceutical Group 104

Nuokang Bio-Pharmaceutical 105

Shenzhen Hepalink Pharmaceutical 106

Simcere Pharmaceutical Group 107

Sinovac Biotech 108

Walvax Biotechnology 110

WuXi PharmaTech 110

CONCLUSIONS: OPPORTUNITIES & CHALLENGES112

Strategic Espicom Analysis 112

MACROENVIRONMENT 112

EPIDEMIOLOGY 112

HEALTHCARE 113

REGULATORY AFFAIRS 113

PRICING & REIMBURSEMENT 114

DISTRIBUTION CHANNELS 114

MARKET 114

COMPETITION 115

OTC PHARMACEUTICALS 115

GENERIC PHARMACEUTICALS116

BIOLOGICS & BIOSIMILARS 116

Radar Analysis 118

SWOT Analysis 118

DIRECTORY 119

GOVERNMENT ORGANISATIONS 119

PHARMACEUTICAL DISTRIBUTORS119

Pharmaceutical Wholesalers 119

Pharmaceutical Retailers 119

PHARMACEUTICAL MANUFACTURERS119

Foreign Pharmaceutical Manufacturers119

Local Pharmaceutical Manufacturers 120

Foreign OTC Manufacturer 120

Local OTC Manufacturer 120

Foreign Generic Manufacturers 120

Local Generic Manufacturers120

Foreign Biologic Manufacturers 120

Local Biologic Manufacturers121

TRADE ORGANISATIONS121 List of Tables

Espicom Analysis of the Pharmaceutical Market, 2012 2Key Data Projections, 2012-2017 3Political Landscape, 2012 4Regional Ranking of Projected Economies, 2017 5Projected Economy, 2012-2017 5Regional Ranking of Projected Demographics, 2017 8Projected Demographics, 2012-2017 8Demographic Indicators, 2004-2010 9Leading Causes of Death, 2010 10Reported Infectious Diseases, 2001-2010 (Rate/100,000 Population) 11Regional Ranking of Projected Health Expenditure, 2017 15Projected Health Expenditure, 2012-201715Healthcare Expenditure by Type, 2000-2009 (CNY Billions) 16Hospitals, 2000-2008 18Hospitals by Region & Municipality, 2008 18Outpatient Institutions by Type, 2001-2008 19Health Centres & Clinics by Region & Municipality, 2008 19Inpatient Admissions, 2002-2008 (Millions) 20 Inpatient Admissions by Type & Institution, 2008 (10,000s) 20Outpatient Visits, 1999-2008 (Millions) 21Outpatient Visits by Type & Institution, 2008 (Millions) 21Regional Ranking of Projected Physicians, 2017 22Projected Physicians, 2012-2017 22Medical Personnel by Type, 2008 (000s) 23Physicians by Region & Municipality, 2008 (000s) 23Chindex Operating Results, 2006-2010 (US$ 000s) 35Chindex Revenue by Business Segment, 2006-2010 (US$000s) 36First China Pharmaceutical Group Operating Results, 2010-2011 (US$ 000s) 36Guangzhou Pharmaceutical Operating Results, 2007-2011 (CNY 000s) 37Hutchison China MediTech Operating Results, 2006-2010 (US$ 000s) 38Jointown Pharmaceutical Group Operating Results, 2007-2010 (CNY 000s) 39Nanjing Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 39Shanghai Pharmaceuticals Revenue by Business Segment, 2009-2010 (CNY 000s) 40Sinopharm Operating Results, 2006-2010 (CNY 000s) 41Sinopharm Revenue by Business Segment, 2006-2010 (CNY 000s) 41Regional Ranking of Projected Pharmaceutical Markets, 2017 43Projected Pharmaceutical Market at Retail Prices, 2012-2017 45Historical Pharmaceutical Market at Retail Prices, 1995-2011 45Pharmaceutical Sales at Retail Prices, 2000-2011 (CNY Billions)46Pharmaceutical Sales by Sector, 2009-2010 (CNY Billions) 47Pharmaceutical & Medical Device Output, 1998-2011 (CNY Billions) 50Pharmaceutical & Medical Device Output by Type, 2010 (CNY Billions) 51Pharmaceutical Exports by Category, 1995-2010 (US$000s) 52Pharmaceutical Exports by Country/Region, 2010 (US$000s) 54Pharmaceutical Imports by Category, 1995-2010 (US$000s) 55Imports of Raw Materials by Country/Region, 2010 (US$000s) 57Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 57Imports of Medicaments by Country/Region, 2010 (US$000s) 58Pharmaceutical Balance of Trade, 1995-2010 (US$000s) 59RDPAC Members, 2011 62AstraZeneca Revenue by Country, 2006-2010 (US$ 000s) 64Dainippon Sumitomo Pharma Revenue, 2010 (¥ 000s) 67Eisai Revenue by Country, 2009-2010 (¥ 000s)68Merck KGaA Revenue by Country & Type, 2010-2011 (€ 000s) 70Novo Nordisk Revenue by Country, 2006-2010 (DKK 000s) 72Sanofi Revenue by Country, 2010 (€ 000s) 75SciClone Revenue, 2006-2010 (US$ 000s) 76Top 25 Local Pharmaceutical Manufacturers by Revenue, 2010 (US$ 000s) 78Beijing Double-Crane Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 79China Pharmaceutical Group Operating Results, 2006-2010 (HK$ 000s) 80China Pharmaceutical Group Revenue by Geographical Area, 2006-2010 (HK$ 000s) 80China Pharmaceutical Group Revenue by Business Segment, 2006-2010 (HK$ 000s) 81Harbin Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 81Joincare Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 82North China Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 83Shanghai Pharmaceuticals Revenue by Business Segment & Drug Type, 2009-2010 (CNY 000s) 84Tianjin Tasly Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 84The United Laboratories International Operating Results, 2006-2010 (HK$ 000s) 85The United Laboratories International Revenue by Geographical Area, 2006-2010 (HK$ 000s) 85The United Laboratories International Revenue by Business Segment, 2006-2010 (HK$ 000s) 86Zhejiang Hisun Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 87Zhejiang Medicine Operating Results, 2006-2010 (CNY 000s)88OTC Pharmaceutical Sales, 2005-2009 (CNY Billions) 89China Sky One Medical Operating Results, 2006-2010 (US$ 000s) 91China Sky One Medical Revenue by Product Area, 2007-2010 (US$ 000s) 91China Pharma Operating Results, 2007-2010 (US$ 000s) 93China Pharma Revenue by Therapeutic Area, 2009-2010 (US$ 000s) 94Shanghai Fosun Pharmaceutical Operating Results, 2007-2010 (CNY 000s) 95Shanghai Fosun Pharmaceutical Revenue by Business Segment, 2007-2010 (CNY 000s) 95NeoStem Operating Results, 2009-2010 (US$ 000s) 983SBIO Operating Results, 2006-2010 (CNY 000s) 993SBIO Foreign Revenue by Geographical Area, 2006-2010 (CNY 000s) 993SBIO Revenue by Product Type, 2006-2010 (CNY 000s) 100Anhui Anke Biotech Operating Results, 2006-2010 (CNY 000s) 101Beijing SL Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 101China Biologic Products Operating Results, 2006-2010 (US$ 000s) 102China Biologic Products Revenue by Product Area, 2006-2010 (US$ 000s) 102Harbin Gloria Pharmaceuticals Operating Results, 2007-2010 (CNY 000s) 103Livzon Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 104Livzon Pharmaceutical Group Operating Income by Product Area, 2006-2010 (CNY 000s) 105Nuokang Bio-Pharmaceutical Operating Results, 2008-2010 (CNY 000s) 106Shenzhen Hepalink Pharmaceutical Operating Results, 2007-2010 (CNY 000s) 107Simcere Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 108Sinovac Biotech Operating Results, 2006-2010 (US$ 000s) 109Sinovac Biotech Revenue by Product Area, 2006-2010 (US$ 000s) 109Walvax Biotechnology Operating Results, 2007-2010 (CNY 000s) 110WuXi PharmaTech Operating Results, 2006-2010 (US$ 000s) 111WuXi PharmaTech Revenue by Business Segment, 2006-2010 (US$ 000s)111WuXi PharmaTech Revenue by Geographical Area, 2006-2010 (US$ 000s)111Espicom Analysis of the Pharmaceutical Market, 2012 117SWOT Analysis of the Pharmaceutical Market, 2012 118

« First ‹ Previous 1 2 3 4 Next › Last »

Select the service that is right for you!

COMPARE ALL SERVICES

Action Alerts PLUS

TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Real Money

TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:

Jim Cramer + 20 Wall Street pros
Intraday commentary & news
Real-time trading forum
Actionable trade ideas

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:

100+ monthly options trading ideas
Actionable options commentary & news
Real-time trading community
Options TV

To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.